Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
If you are manufacturing, importing or supplying MDMA and psilocybine products for therapeutic use in Australia, there are rules you must follow.
As MDMA and psilocybine are unapproved therapeutic goods, they can be legally supplied through clinical trials or by an authorised psychiatrist under the Authorised Prescriber Scheme.
You are responsible for ensuring that an exemption or authorisation is in place before supplying these products.
You must meet certain obligations to legally supply therapeutic goods in Australia. This section contains guidance and information specific to unapproved therapeutic goods. You may also have to meet obligations that apply to all unapproved therapeutic goods and all products.